Irene H. Langbakke

Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira)

John B. Buse, Tina Vilsbøll, Jerry Thurman et al. · Diabetes Care · 2014 · 253 citations

Medicine, Pharmacology, Pharmacotherapy +17

Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile

Jerrold H. Levy, Abe Fingerhut, Thomas Brott et al. · Transfusion · 2006 · 104 citations

Medicine, Hematology, Pharmacotherapy +17

PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial

Michael J. Koren, Olivier Descamps, Yoshiki Hata et al. · The Lancet Diabetes & Endocrinology · 2024 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges

Allen B. King, Athena Philis‐Tsimikas, Eric S. Kilpatrick et al. · Diabetes Technology & Therapeutics · 2017 · 26 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17